In trading on Tuesday, shares of Tarsus Pharmaceuticals Inc (Symbol: TARS) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $39.25 per share.

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The ...

One trend is becoming increasingly clear: people are spending more time on conversational platforms. Apps like WhatsApp and Instagram have become the primary means through which billions connect—not ...

Tarsus Pharmaceuticals, Inc. (TARS) earnings report: revenue, EPS, surprise, history, news and analysis. Skip to content Home page Seeking Alpha - Power to Investors ...

The current price of TARS AI (TAI) is $0.102869, as of Jun 16, 2025. Over the last 24 hours, the price has moved by 2.53%, with a change of 0.11% in the past hour. For longer-term performance, the ...

Current board members & directors are RAHULKUMAR KAMALNAYAN BAJAJ, SANJIVNAYAN RAHULKUMAR BAJAJ, NIRAJKUMAR RAMKRISHNAJI BAJAJ, SHEKHARKUMAR RAMKRISHNAJI BAJAJ, NIKHIL GUNVANT TARKAS, VINOD KESHAVDEO ...

DUBAI, 30th October, 2021 (WAM) -- Dubai’s Roads and Transport Authority (RTA) has launched an online Transportation Activities Rental System (TARS) to serve the car rental system in the emirate. The ...

Tarsus Pharmaceuticals Inc. (TARS) Company Bio Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a ...